You are here

  • Home
  • Archive
  • Volume 77, Issue 9
  • Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRI…

Article metrics

Article menu

Download PDFPDF

Clinical and epidemiological research
Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study)

 

Online download statistics by month:

Online download statistics by month: May 2018 to March 2024

AbstractFullPdf
May 201830230461
Jun 2018179418411046
Jul 201813311337507
Aug 2018948948352
Sep 2018566564252
Oct 2018257257116
Nov 201818718779
Dec 201813013040
Jan 2019999834
Feb 201911011136
Mar 201913613556
Apr 2019929233
May 201910810735
Jun 201910710338
Jul 201911110628
Aug 201910610622
Sep 20191009946
Oct 2019979337
Nov 2019929023
Dec 2019676618
Jan 202011411439
Feb 2020949137
Mar 202012011937
Apr 2020848421
May 2020868261
Jun 2020838240
Jul 2020908931
Aug 2020827538
Sep 20201029631
Oct 2020908033
Nov 2020756637
Dec 2020646020
Jan 2021928825
Feb 2021514625
Mar 2021878834
Apr 2021969230
May 2021878521
Jun 2021837927
Jul 2021696525
Aug 202110810425
Sep 202111911825
Oct 202113412836
Nov 2021979624
Dec 2021706817
Jan 202211010319
Feb 2022717213
Mar 202236435623
Apr 2022938930
May 202225024729
Jun 202210810418
Jul 2022939018
Aug 202213112913
Sep 20221049915
Oct 202212211724
Nov 2022737122
Dec 2022525022
Jan 2023757215
Feb 202316416118
Mar 2023615917
Apr 2023696315
May 2023736927
Jun 2023706916
Jul 2023444311
Aug 2023818019
Sep 2023676513
Oct 202390907
Nov 2023959510
Dec 202313213015
Jan 2024696215
Feb 2024817118
Mar 202415214913
Total11811116744073